L26/P-003 Improved intrauterine insemination strategies impact live birth success rates and enable inclusion of male factor infertility alongside unexplained infertility
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von G. Bahadur und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What are the key factors that improve live birth rates (LBR) for women over 35 years undergoing gonadotrophin-induced intrauterine insemination (IUI) treatment? Summary answer Total motile sperm count, follicle number, and maternal age influenced LBRs. IUI success can be achieved with selected male-factor infertility cases alongside unexplained infertility. What is known already While IVF dominates globally, many couples lack access to complex technology, making IUI a vital alternative. Efforts now focus on improving IUI LBRs and addressing factors affecting success. ESHRE recommends IUI before IVF for unexplained infertility, while IVF/ICSI is prioritised for male-factor cases. Data on IUI outcomes for male-factor infertility remain limited, though pregnancies with <5 × 106 sperm are reported. OHSS risk with gonadotrophin stimulation and multiple gestation must be balanced individually. Optimal IUI cycle numbers remain unclear. Could consecutive ejaculations (CE) pooled sperm help surpass sperm thresholds? Addressing these gaps in this study is essential to uphold patient care. Study design, size, duration This retrospective cohort study (2010–2019) analysed 596 IUI cycles, including 366 controls and 230 CE cycles in nulliparous women >35 years with prior IVF failures. Cases with <5 × 106 motile sperm were profiled with CE. Cancelled cycles were included in calculations. LBR were compared using odds ratios, and age differences were assessed with t-tests. Data were tested for normality (Shapiro–Wilk), with Chi-squared, t-tests, Mann-Whitney, Kruskal-Wallis, and Jonckheere-Terpstra applied. Significance was defined as P < 0.05. Participants/materials, setting, methods This UK single-centre retrospective study analysed 596 IUI cycles in nulliparous women >35 years, including some with prior IVF failures. Inclusion required ≥1 year subfertility; exclusions were cancer, tubal disease, sterilization reversal, multiparity, or donor sperm. Gonadotropin stimulation (150IU Menopur, alternate days) with hCG trigger preceded IUI. Luteal support used Cyclogest 400 mg pessaries. OHSS and multiple birth risks were managed. CE sperm preparation maximised motile recovery. Outcomes reported as LBR. Main results and the role of chance Of 596 IUI cycles, 230 involved CE (male factor infertility) and 366 served as controls (unexplained infertility). Per-cycle LBR was 11.3% in CE versus 13.1% in controls (p = 0.60), with per-woman rates of 26.5% and 29.1% (p = 0.76). Mean female age was similar (37.2 vs 37.7 years, p = 0.29). Success was strongly associated with motile sperm counts >10 × 106, yielding 65% of LB in CE and 87.5% in controls. Follicle number influenced outcomes: LBR/cycle rose from 10.2% to 17.4% in CE and from 12% to 17.9% in controls when two follicles developed, though differences were not statistically significant. Only one twin pregnancy occurred, reflecting minimal multiple gestation risk. Across six cycles, LBR remained consistent, supporting the clinical justification for offering up to six IUI attempts. Odds ratios showed no significant differences between early and later cycles. Weekday scheduling constraints did not materially affect outcomes. Overall, CE broadened IUI’s scope to include selected cases of male factor infertility, achieving comparable success to unexplained infertility. Crucially, IUI LBR in women >35 matched UK IVF single embryo transfer (SET) results, a clinically significant benchmark underscoring IUI’s role as a cost-effective, less invasive alternative. Importantly, no adverse cycle cancellations occurred due to CE failure, reinforcing procedural reliability. Limitations, reasons for caution This retrospective, single-centre study included heterogeneous patients, some with failed IVF. Resource-driven weekday restrictions and limited sperm/ovarian reserve data may affect reproducibility. Although consistent operators ensured procedural uniformity and CE cancellations were avoided, modest sample size and the retrospective design limits generalisability, yet findings remain clinically relevant within this context. Wider implications of the findings Re-evaluating the 5 × 106 sperm threshold for IUI is essential, impacting DI programmes. In women >35, IUI LBR parallels UK IVF SET outcomes. Male factor cases previously fast-tracked to IVF/ICSI achieve comparable LBR, a transformative shift in IUI. For women >39, three follicles should be considered, broadening patient options and strategies. Trial registration number No
Zitieren
APA
Bahadur, G., Homburg, R., Henkel, R., Acharya, S., Kanna, J., Woodward, B., Muneer, A., Huirne, J., Govind, A., Illahibuccus, A., Al-Habib, A., & Jauniaux, E. (2026). L26/P-003 Improved intrauterine insemination strategies impact live birth success rates and enable inclusion of male factor infertility alongside unexplained infertility. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.339
Vancouver
Bahadur G, Homburg R, Henkel R, Acharya S, Kanna J, Woodward B, et al. L26/P-003 Improved intrauterine insemination strategies impact live birth success rates and enable inclusion of male factor infertility alongside unexplained infertility. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.339
BibTeX
@article{Bahadur2026,
author = {Bahadur, G. and Homburg, R. and Henkel, R. and Acharya, S. and Kanna, J. and Woodward, B. and Muneer, A. and Huirne, J.A.F. and Govind, A. and Illahibuccus, A. and Al-Habib, A. and Jauniaux, E.},
title = {L26/P-003 Improved intrauterine insemination strategies impact live birth success rates and enable inclusion of male factor infertility alongside unexplained infertility},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.339}
}
EUVIMED